A study to learn how effective and safe the drug “mirabegron” is and how long it stays in the body of children aged 6 months to less than 3 years of age with neurogenic detrusor overactivity

Category Primary study
Registry of TrialsClinical Trials Information System
Year 2025
This article has no abstract
Epistemonikos ID: 60e1efc66ecdba5b50faf6335e553a44472e1092
First added on: Jan 16, 2026